tiprankstipranks
Trending News
More News >
Arcellx Inc (ACLX)
NASDAQ:ACLX
US Market

Compare Arcellx Inc (ACLX) vs. Competitors

Compare
297 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arcellx Inc
$68.94
$3.95B
-17.59
2.88%
17 Buy
1 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$81.99
$5.30B
129.44
124.38%
11 Buy
1 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$19.94
$2.60B
67.16
-32.93%
10 Buy
6 Hold
0 Sell
Moderate Buy
Immunovant
$26.27
$5.24B
-9.29
10.38%
7 Buy
2 Hold
0 Sell
Strong Buy
Beam Therapeutics
$31.22
$3.25B
-7.04
33.42%
10 Buy
3 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$16.76
$1.17B
-5.04
-59.59%
9 Buy
1 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACLX
Arcellx Inc
68.94
2.37
3.56%
PTGX
Protagonist Therapeutics
81.99
43.89
115.20%
APLS
Apellis Pharmaceuticals
19.94
-10.19
-33.82%
IMVT
Immunovant
26.27
2.68
11.36%
BEAM
Beam Therapeutics
31.22
6.69
27.27%
MLTX
MoonLake Immunotherapeutics
16.76
-29.06
-63.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts